Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

691
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
691
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps.

Journal of human hypertension·2026
Same author

Healthcare insurance status and hypertension control before and after the Affordable Care Act.

American journal of hypertension·2026
Same author

Predicted Cardiovascular and Economic Impacts of the Measure Accurately, Act Rapidly, and Partner With Patients Program to Improve Hypertension Control.

American journal of preventive medicine·2025
Same author

Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Non-debatable issues in defining blood pressure targets for hypertension - Editorial.

Blood pressure·2025
Same author

Treatment in the First Month After Hypertension Diagnosis Improves Blood Pressure Control.

Hypertension (Dallas, Tex. : 1979)·2025

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Pre-hypertension: rationale for pharmacotherapy.

Brent M Egan1, Marilyn A Laken

  • 1School of Medicine Greenville, Greenville Health System, Care Coordination Institute, University of South Carolina, Greenville, SC, USA, began@carecoordinationinstitute.org.

Current Hypertension Reports
|October 22, 2013
PubMed
Summary

Pre-hypertension significantly elevates risks for hypertension and cardiovascular events. Clinical trials in African Americans are needed to address racial disparities in hypertension and improve health equity.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.1K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.1K

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • Pre-hypertension (blood pressure 120-139/80-89 mmHg) affects millions in the US, with elevated readings increasing risks for hypertension and cardiovascular events.
  • Current guidelines recommend lifestyle interventions for pre-hypertension, but population effectiveness is limited by lifestyle factors.
  • African Americans experience a faster progression from pre-hypertension to hypertension compared to Caucasians, highlighting a significant health disparity.

Purpose of the Study:

  • To investigate the potential of antihypertensive medications in treating pre-hypertension.
  • To explore the feasibility and merit of clinical trials targeting African Americans with pre-hypertension.
  • To provide a foundation for guidelines aimed at reducing racial disparities in hypertension and related diseases.

Main Methods:

  • Review of existing evidence on pre-hypertension risks and interventions.
  • Analysis of racial differences in hypertension progression.
  • Proposal for targeted clinical trials in African American populations.

Main Results:

  • Individuals with pre-hypertension face significantly higher risks of developing hypertension and cardiovascular issues.
  • Antihypertensive medications can be safely used to reduce incident hypertension in pre-hypertensive individuals.
  • Racial disparities exist in the transition from pre-hypertension to hypertension, with African Americans progressing more rapidly.

Conclusions:

  • Clinical trials in African Americans with pre-hypertension are warranted to address and eliminate racial disparities in hypertension.
  • Effective interventions could improve racial equity in hypertension prevalence and reduce associated cardiovascular and renal complications.
  • Evidence supports the use of antihypertensive medications for individuals with pre-hypertension to mitigate risks.